Renaissance Technologies (RenTech)'s ADPT Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 302,800 shares of Adaptive Biotechnologies Corporation (ADPT) worth $6.5 M, representing 0.01% of the portfolio. First purchased in 2021-Q1, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in ADPT, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2022, adding 455,600 shares. Largest reduction occurred in Q3 2023, reducing 287,300 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Adaptive Biotechnologies Corporation (ADPT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Adaptive Biotechnologies Corporation (ADPT) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +63,000 | Add 26.27% | 302,800 | $21.45 |
| Q1 2026 | +239,800 | New Buy | 239,800 | $13.88 |
| Q4 2025 | -279,700 | Sold Out | 0 | $0.00 |
| Q3 2025 | +229,800 | Add 460.52% | 279,700 | $14.96 |
| Q2 2025 | -55,985 | Reduce 52.87% | 49,900 | $11.65 |
| Q1 2025 | -123,900 | Reduce 53.92% | 105,885 | $7.43 |
| Q4 2024 | +60,385 | Add 35.65% | 229,785 | $5.99 |
| Q3 2024 | +17,600 | Add 11.59% | 169,400 | $5.12 |
| Q2 2024 | +99,217 | Add 188.69% | 151,800 | $3.62 |
| Q1 2024 | +52,583 | New Buy | 52,583 | $3.21 |
| Q4 2023 | -51,200 | Sold Out | 0 | $0.00 |
| Q3 2023 | -287,300 | Reduce 84.87% | 51,200 | $5.45 |
| Q2 2023 | -55,500 | Reduce 14.09% | 338,500 | $0.01 |
| Q1 2023 | -21,800 | Reduce 5.24% | 394,000 | $0.01 |
| Q4 2022 | -42,000 | Reduce 9.17% | 415,800 | $0.01 |
| Q3 2022 | -28,700 | Reduce 5.90% | 457,800 | $7.12 |
| Q2 2022 | +30,900 | Add 6.78% | 486,500 | $8.09 |
| Q1 2022 | +455,600 | New Buy | 455,600 | $13.88 |
| Q2 2021 | -160,200 | Sold Out | 0 | $0.00 |
| Q1 2021 | +160,200 | New Buy | 160,200 | $40.26 |
Renaissance Technologies (RenTech)'s Adaptive Biotechnologies Corporation Investment FAQs
Renaissance Technologies (RenTech) first purchased Adaptive Biotechnologies Corporation (ADPT) in Q1 2021, acquiring 160,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Adaptive Biotechnologies Corporation (ADPT) for 20 quarters since Q1 2021.
Renaissance Technologies (RenTech)'s largest addition to Adaptive Biotechnologies Corporation (ADPT) was in Q1 2022, adding 455,600 shares worth $6.32 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 302,800 shares of Adaptive Biotechnologies Corporation (ADPT), valued at approximately $6.5 M.
As of the Q2 2026 filing, Adaptive Biotechnologies Corporation (ADPT) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Adaptive Biotechnologies Corporation (ADPT) was 486,500 shares, as reported at the end of Q2 2022.